PT895988E - Derivados do acido arilsulfonilamino-hidroxamico - Google Patents

Derivados do acido arilsulfonilamino-hidroxamico

Info

Publication number
PT895988E
PT895988E PT98305959T PT98305959T PT895988E PT 895988 E PT895988 E PT 895988E PT 98305959 T PT98305959 T PT 98305959T PT 98305959 T PT98305959 T PT 98305959T PT 895988 E PT895988 E PT 895988E
Authority
PT
Portugal
Prior art keywords
arylsulphonylamino
aryl
acid derivatives
hydroxamic acid
angiogenisis
Prior art date
Application number
PT98305959T
Other languages
English (en)
Inventor
Ralph Pelton Robinson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT895988E publication Critical patent/PT895988E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
PT98305959T 1997-08-08 1998-07-27 Derivados do acido arilsulfonilamino-hidroxamico PT895988E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5520897P 1997-08-08 1997-08-08

Publications (1)

Publication Number Publication Date
PT895988E true PT895988E (pt) 2002-09-30

Family

ID=21996365

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98305959T PT895988E (pt) 1997-08-08 1998-07-27 Derivados do acido arilsulfonilamino-hidroxamico

Country Status (9)

Country Link
EP (1) EP0895988B1 (pt)
JP (1) JPH11116549A (pt)
AT (1) ATE217863T1 (pt)
BR (1) BR9803128A (pt)
CA (1) CA2244501C (pt)
DE (1) DE69805473T2 (pt)
DK (1) DK0895988T3 (pt)
ES (1) ES2176913T3 (pt)
PT (1) PT895988E (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
PA8469601A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimiento para alquilar sulfonamidas impedidas estericamente
PA8469301A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimientos para la preparacion de acidos hidroxamicos.
AU3196300A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
ES2200783T3 (es) * 1999-03-31 2004-03-16 Pfizer Products Inc. Acidos dioxociclopentil hidroxamicos.
IL138686A0 (en) * 1999-10-01 2001-10-31 Pfizer Prod Inc α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
IL151250A0 (en) 2000-03-21 2003-04-10 Procter & Gamble Difluorobutyric acid metalloprotease inhibitors
BR0109328A (pt) * 2000-03-21 2003-06-10 Procter & Gamble Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
WO2001077092A1 (en) * 2000-04-07 2001-10-18 Samsung Electronics Co., Ltd. Sulfonamide derivative as a matrix metalloproteinase inhibitor
AU2002256672A1 (en) * 2001-03-14 2002-09-24 Novartis Ag Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
CN103232539B (zh) 2001-06-26 2015-06-03 安姆根弗里蒙特公司 抗opgl抗体
US7176217B2 (en) 2001-11-13 2007-02-13 Shiseido Co., Ltd. Azabicyclo compound matrix metalloprotease inhibitor and skin preparation
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
EP1466899A4 (en) 2001-12-27 2010-01-06 Dainippon Sumitomo Pharma Co "HYDROXAMIC ACID DERIVATIVE AND MMP INHIBITOR CONTAINING THEM AS AN ACTIVE SUBSTANCE"
MXPA05007019A (es) 2002-12-30 2005-08-18 Amgen Inc Terapia de combinacion con factores co-estimuladores.
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
EP1694410B1 (en) 2003-12-15 2010-04-14 Japan Tobacco, Inc. Cyclopropane derivatives and pharmaceutical use thereof
ZA200605247B (en) * 2003-12-15 2007-10-31 Japan Tobacco Inc N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690703B2 (en) * 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
PL331895A1 (en) * 1996-08-23 1999-08-16 Pfizer Arylosulphonylamino derivatives of hydroxamic acid

Also Published As

Publication number Publication date
ATE217863T1 (de) 2002-06-15
DK0895988T3 (da) 2002-09-09
EP0895988A1 (en) 1999-02-10
DE69805473T2 (de) 2003-01-16
EP0895988B1 (en) 2002-05-22
BR9803128A (pt) 2000-05-02
CA2244501C (en) 2003-03-18
DE69805473D1 (de) 2002-06-27
JPH11116549A (ja) 1999-04-27
ES2176913T3 (es) 2002-12-01
CA2244501A1 (en) 1999-02-08

Similar Documents

Publication Publication Date Title
PT895988E (pt) Derivados do acido arilsulfonilamino-hidroxamico
EP0818442A3 (en) Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
MY113586A (en) Aylsulfonylamino hydroxamic acid derivatives
MX9708026A (es) Derivados del acido arislfulfonil hidroxamico, composiciones que los contienen y uso de los mismos.
FR2744010B1 (fr) Procede de fabrication d'implants osseux
MY121754A (en) Arylsulfonylamino hydroxamic acid derivatives
WO2004024081A3 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
DK0738107T3 (da) Inhibitorer for fedtsyresyntese som antimikrobielle midler
AP9801174A0 (en) Cyclic sulfone derivatives.
GB8919251D0 (en) Compounds
NZ330922A (en) Hydroxamic acid derivatives substituted by a series of 2-pyrrolidinones, hydantoins, and pyrazolidinones for use with the treatment of diseases related to connective tissue degradation
CA2343204A1 (en) Arylsulfonanilide ureas
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
IT1232670B (it) Procedimento per la purificazione delle acque reflue prodotte dagli impianti di produzione dell'urea.
MX9707692A (es) Acido aza bisfosfonicos herbicidas y composiciones que los contienen.
ATE244229T1 (de) Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren
BR9911010A (pt) Inibidores de sucinamida de enzima de conversão da interleucina-1beta
CA2340138A1 (en) 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
TNSN05067A1 (en) Acetyl 2-hydroxy- 1,3 diaminoalkanes
WO2000015208A3 (en) New use of immunosupressants for mmp-mediated diseases
PT826681E (pt) Derivados de acido epoxi-succinico
CA2253796A1 (en) Inhibition of matrix metalloproteases by acetylene containing compounds
TW363056B (en) Inhibition of matrix metalloproteases by substituted phenethyl compounds
CA2397960A1 (en) Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
PL296314A2 (en) Method of obtaining novel derivatives of tridiazinones